eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors
2/2019
vol. 11
 
Share:
Share:
more
 
 
abstract:
Review paper

The role of peripherally acting mu-opioid receptor antagonists (PAMORA) in the treatment of constipation in palliative care

Tomasz Dzierżanowski

Medycyna Paliatywna 2019; 11(2): 51-57
Online publish date: 2019/07/18
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Opioid-induced constipation (OIC) is the most common adverse effect of opioid analgesics. Its treatment is difficult and depends to a large extent on multiple overlapping dietary, behavioral, disease-related, and iatrogenic causes. The prevention of constipation is mandatory, along with the initiation of opioid use. In the treatment of OIC, regular laxatives are recommended, despite their poor effectiveness. In the case of ineffectiveness, one of the peripherally acting m opioid receptor antagonists (PAMORA), such as methylnaltrexone, naloxegol, or naldemedine, should be used. After achieving bowel movements, the treatment with antagonist should be continued.
keywords:

constipation, palliative care, peripherally acting m opioid receptor antagonists, PAMORA

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe